Fig. 1From: Perturbation and resilience of the gut microbiome up to 3 months after β-lactams exposure in healthy volunteers suggest an important role of microbial β-lactamasesDesign and sampling times of the CEREMI clinical trial. Systems depicted in red were classified as high dimensionality, and systems depicted in blue as low dimensionalityBack to article page